manilatimes12h
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference ...
Le Lézard12h
Teva and Alvotech Announce SELARSDItm (ustekinumab-aekn) Injection Now Available in the U.S.
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDItm for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination ...
Medscape16h
Antibiotics Getting False Blame for Colitis, Study Finds
A nationwide study of older adults in Sweden suggests a suspected link between antibiotic use and microscopic colitis is more ...
News Medical on MSN7h
Exploring EGCG's role in protecting against acetaminophen-induced liver injury
Announcing a new publication for Acta Materia Medica journal. Excessive consumption of acetaminophen (APAP) has emerged as the primary culprit behind drug-induced liver injury (DILI), with ...
JNJ met main goal in late-stage trial for ulcerative colitis treatment
Johnson & Johnson (JNJ) said on Friday that its late-stage study of TREMFYA as an induction therapy for adults with ...